Products may be contaminated with bacteria that can cause serious infections read on >
DermaRite Expands Recall of Creams and Sanitizers Over Infection Risk
A little about: Weekly Sauce
All Sauce from Weekly Sauce:
Wegovy Linked To Lower Heart Risks Than Similar Drugs, Study Shows
The weight-loss drug Wegovy may lower the risk of heart attack, stroke or death more than similar medications, according to new research from its maker, Novo Nordisk. In a study of more than 21,000 patients with obesity and heart disease but no diabetes, those taking Wegovy — which contains the active ingredient semaglutide — saw… read on > read on >
Taylor Fresh Foods Issues Recall of Salad Kits Sold at Kroger, Walmart
Wrong dressing packets that were included contain undeclared sesame and soy read on >
One Dose of RSV Vaccine May Shield Older People for Two Seasons
A single dose of RSV vaccine might protect seniors for two cold and flu seasons in a row, a new study says. Vaccination reduced seniors’ risk of hospitalization by 58% during two RSV seasons, researchers reported Aug. 30 in the Journal of the American Medical Association. “These results clearly demonstrate that the RSV vaccines prevent… read on > read on >
Chatbots Give Users ‘Inconsistent’ Info on Suicide, Study Finds
Many people with suicidal thoughts are turning to artificial intelligence (AI) chatbots for comfort and advice, and these programs might not be completely up to the challenge, a new study says. Chatbots respond appropriately when asked questions that reflect a very low or very high risk of suicide, providing factual answers or refusing to answer… read on > read on >
Could Diabetes Drug Metformin Change Metal Levels in Your Blood?
The diabetes drug metformin has been a mystery for more than six decades. The most prescribed diabetes med in the world, metformin is very effective in lowering blood sugar levels. But no one knows exactly how it works. But a new study sheds some light on metformin’s magic, potentially opening the door for development of… read on > read on >
Study Casts Doubt on Use of Beta Blockers Post-Heart Attack, Especially for Women
A drug commonly prescribed to heart attack survivors may not benefit many of them, a new clinical trial has found. Beta-blockers do not appear to reduce the risk of death, a second heart attack or heart failure in people’s whose hearts weren’t damaged by the life-threatening event, results reveal. The findings are expected to overturn… read on > read on >
FDA Approves Subcutaneous Leqembi for Treatment of Early Alzheimer Disease
Leqembi Iqlik allows for at-home maintenance dosing after initial 18 months of intravenous dosing read on >
CVS, Walgreens Limit COVID Vaccines in Some States as Rules Shift
CVS and Walgreens are changing where and how they offer COVID-19 vaccines this season as they work to comply with state laws and current U.S. Centers for Disease Control and Prevention (CDC) guidelines. Both pharmacy chains say vaccine access will now vary by state. CVS announced that it can only offer COVID-19 shots in the… read on > read on >
Heart Failure Strikes Black Americans Almost 14 Years Earlier Than White Americans
Disparities in education and access to insurance mean that heart failure hits Black American adults nearly 14 years earlier than it does white Americans, new research shows. Among Black patients, heart failure typically sets in at about 60 years of age, compared to 73.6 on average for white patients. The study, conducted by researchers at… read on > read on >